Key result
Greater early systolic lengthening amplitude is linked to increased cardiovascular death risk after CABG.
Why the study?
Early systolic lengthening has been linked to loss of myocardial viability and contractile dysfunction, but its long-term prognostic value in CABG patients required assessment.
Does early systolic lengthening assessed by speckle tracking echocardiography predict cardiovascular death and all-cause mortality in patients undergoing coronary artery bypass graft surgery?
Cohort (n=709)
Single-blind (investigator blinded to clinical information and outcomes)
No
Does early systolic lengthening assessed by speckle tracking echocardiography predict cardiovascular death and all-cause mortality in patients undergoing coronary artery bypass graft surgery?
Early systolic lengthening assessed by speckle tracking echocardiography provides independent and incremental prognostic value beyond the EuroSCORE II for predicting mortality in patients undergoing CABG.
BACKGROUND: Early systolic lengthening (ESL), a paradoxical stretch of myocardial fibers, has been linked to loss of myocardial viability and contractile dysfunction. We assessed the long-term prognostic potential of ESL in coronary artery bypass graft (CABG) patients. METHODS: We retrospectively included patients (n = 709; mean age 68 years; 85% men) who underwent speckle tracking echocardiography (median 15 days) prior to CABG. Endpoints were cardiovascular death (CVD) and all-cause mortality. We assessed amplitude of ESL (%), defined as peak positive strain, and duration of ESL (ms), determined as time from Q-wave on the ECG to peak positive strain. We applied Cox models adjusted for clinical risk assessed as EuroSCORE II. RESULTS: During median follow-up of 3.8 years [IQR 2.7-4.9 years], 45 (6%) experienced CVD and 80 (11%) died. In survival analyses adjusted for EuroSCORE II, each 1% increase in amplitude of ESL was associated with CVD (HR 1.35 [95%CI 1.09-1.68], P = 0.006) and all-cause mortality (HR 1.29 [95%CI 1.08-1.54], P = 0.004). Similar findings applied to duration of ESL (per 10ms increase) and CVD (HR 1.12 [95%CI 1.02-1.23], P = 0.016) and all-cause mortality (HR 1.09 [95%CI 1.01--1.17], P = 0.031). The prognostic value of ESL amplitude was modified by sex (P interaction < 0.05), such that the prognostic value was greater in women for both endpoints. When adding ESL duration to EuroSCORE II, the net reclassification index improved significantly for both CVD and all-cause mortality. CONCLUSIONS: Assessment of ESL provides independent and incremental prognostic information in addition to the EuroSCORE II for CVD and all-cause mortality in CABG patients.
No takes yet. Share an insight, caveat, or question.
Brainin et al. (2021) conducted a cohort in Coronary artery disease undergoing coronary artery bypass grafting (CABG) (n=709). Early systolic lengthening (ESL) amplitude (per 1% increase) vs. Lower ESL amplitude (continuous per 1% increase) was evaluated on Cardiovascular death (HR 1.35, 95% CI 1.09-1.68, p=0.006). Each 1% increase in early systolic lengthening amplitude independently increased the risk of cardiovascular death (HR 1.35, 95% CI 1.09-1.68, P=0.006) in CABG patients after EuroSCORE II adjustment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: